According to the findings, Xenon’s top medication candidate, azetukalner, will likely exhibit similarly encouraging outcomes in its Phase III data, which is expected to be released early next year.

Is MCU Phase 4 directionless? Today we examine the direction of the Marvel Cinematic Universe with Phase 4 and where they seem to be failing. Does MCU Phase 4 suck?

FALCON-HD is a Phase 2/3 randomized, double-blind, placebo-controlled, dose ranging study to evaluate the pharmacodynamics, safety, and efficacy of SKY-0515 in participants with Stage 2 and early ...

Xenon signals Phase 3 epilepsy readout in early 2026 with expanded pipeline advancements May 12, 2025 10:07 PM ET Xenon Pharmaceuticals Inc. (XENE) Stock AI-Generated Earnings Calls Insights Play ...

PTC Therapeutics Inc. CEO Matthew Klein said the firm “achieved all we set out to [achieve] in phase II” with PTC-518 in Huntington’s disease (HD), but it wasn’t enough to excite Wall Street, as some ...

The long-awaited transition of Finand’s broadcast television to high definition has begun with the transfer of YLE’s channels to the HD format in DVB-T2.

Xenon Pharmaceuticals anticipates key Phase 3 data for azetukalner in 2025, expanding its ion channel portfolio and clinical trials.

Harley-Davidson has unveiled a second phase of renovations which will take place at its headquarters campus.